Athyrium Capital Management

Private Investment Firm New York, New York, United States ·Founded 2008

Overview

Athyrium Capital is a specialized asset management company with a focus on the global healthcare sector. Athyrium invests in a wide range of financial instruments including royalties, structured credit, and equities as well as select special situations.

Investment Focus

  • Commercial-stage companies
  • Compelling products
  • Differentiated services
  • Global presence

Portfolio Companies

Crown LaboratoriesBasilea PharmaceuticaCalliditas TherapeuticsChoice Health At HomeCoherus BiosciencesEsperion TherapeuticsUnlock Health

Get the full list of 54,000+ investors

Athyrium Capital Management and every other firm and angel in the database — as one spreadsheet you keep.

$19one-time payment · no subscription
  • All 54,000+ investors — VC firms, private equity, family offices and angels
  • The key person to contact at each one, with their job title
  • Their work email address
  • Their phone number
  • Their LinkedIn profile
  • Delivered as a single .xlsx file — download it as many times as you like
Get the full list — $19 → One payment. No seats, no credits, no expiry. Already bought it? Sign in to download it again — no second payment.

Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.

Frequently asked questions about Athyrium Capital Management

What sectors does Athyrium Capital Management invest in?

Athyrium Capital Management invests in Healthcare Services, Medical Devices, Biopharmaceuticals and Healthcare Information Technology, and is based in New York, New York, United States. Athyrium Capital Management is listed as a private investment firm in the ConnectSafely investor database.

What stage does Athyrium Capital Management invest at?

Athyrium Capital Management backs companies at Growth, Late Stage, Pre-IPO and Buyout, writing cheques of 25M - 150M.

Which regions does Athyrium Capital Management invest in?

Athyrium Capital Management invests across United States, Australia, Europe and Asia.

Who are the partners at Athyrium Capital Management?

Team members listed for Athyrium Capital Management include Elin Strong (Chief Financial Officer) and Paul Wakefield (Chief Financial Officer).

What companies has Athyrium Capital Management invested in?

Athyrium Capital Management's portfolio includes Crown Laboratories, Basilea Pharmaceutica, Calliditas Therapeutics, Choice Health At Home, Coherus Biosciences, Esperion Therapeutics and Unlock Health.

How do I contact Athyrium Capital Management?

Athyrium Capital Management's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.

Last updated · Source: ConnectSafely investor database